Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “AXSOME THERAPEUTICS, INC.”

127 pharma patents match "AXSOME THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 127
Index total 30,257
Page 1 / 6

Quick answer

This filtered view shows 127 pharmaceutical patents matching "AXSOME THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

127 results for “AXSOME THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 12370196

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted

  2. US 12357697

    Pharmaceutical compositions comprising bupropion and cysteine

    AXSOME THERAPEUTICS, INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted

  3. US 12357640

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted

  4. US 12268693

    Pharmaceutical compositions comprising a tolfenamic acid

    AXSOME THERAPEUTICS, INC. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  5. US 12246023

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted

  6. US 12156914

    Pharmaceutical compositions comprising bupropion and cysteine

    AXSOME THERAPEUTICS, INC. · Granted Dec 3, 2024 · Expires Nov 28, 2044

    granted

  7. US 12128052

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted

  8. US 12115165

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted

  9. US 12102606

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted

  10. US 12005118

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted

  11. US 11998552

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted

  12. US 11957686

    Compositions for delivery of reboxetine

    AXSOME THERAPEUTICS, INC. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted

  13. US 11944683

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted

  14. US 11883408

    Reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted

  15. US 11865117

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted

  16. US 11826370

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  17. US 11826354

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  18. US 11806354

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  19. US 11801250

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted

  20. US 11786488

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  21. US 11759522

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  22. US 11738085

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted

  23. US 11712441

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted

  24. US 11660274

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted May 30, 2023 · Expires May 25, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.